- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07596836
Sprint Interval Training in Young Sedentary Adults (SIT)
Effects of Sprint Interval Training on Cardiovascular Capacity and VO2max in Young Sedentary Adults: A Randomized Controlled Trial
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study was designed as a randomized controlled pre-test and post-test intervention study. Healthy sedentary adults aged 20 to 25 years were enrolled after ethics approval and written informed consent. Participants were randomly allocated in a 1:1 ratio to either a supervised sprint interval training group or a control group.
The sprint interval training group performed supervised exercise sessions on a cycle ergometer three times per week for 6 weeks. Each session included a 5-minute warm-up, followed by repeated 30-second all-out sprint bouts with active recovery periods. The number of sprint repetitions was progressively increased during the intervention period. The control group maintained their usual sedentary lifestyle and did not receive an additional exercise program.
Outcome measurements were performed before and after the intervention. The primary outcome was VO2max, assessed using a maximal exercise test on a cycle ergometer with respiratory gas analysis. Secondary outcomes were resting heart rate and 6-minute walk test distance. Adherence and adverse events were monitored throughout the study period.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ankara
-
Ankara, Ankara, Turquía (Türkiye), 06000
- Ankara Demirspor
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Aged 20-25 years
- Healthy sedentary adult
- Engaging in less than 150 minutes/week of moderate-to-vigorous physical activity
- IPAQ score below 600 MET-min/week or not participating in a regular exercise program
- Willing to provide written informed consent
Exclusion Criteria:
- History of cardiovascular, pulmonary, or metabolic disease, such as hypertension or diabetes
- Musculoskeletal injury or orthopedic condition preventing exercise participation
- Pregnancy or breastfeeding
- Smoking
- Regular medication use
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Sprint Interval Training Group
Participants in this group completed supervised sprint interval training sessions on a cycle ergometer three times per week for 6 weeks.
|
The sprint interval training intervention consisted of supervised cycle-ergometer sessions performed three times per week for 6 weeks.
Each session included a 5-minute warm-up at 50% VO2max, followed by 4 to 6 repetitions of 30-second all-out sprint bouts on a Monark 894E cycle ergometer, with 4-minute active recovery periods between sprints.
The number of sprint repetitions was progressively increased from 4 repetitions in the first two weeks to 6 repetitions in the following four weeks.
Otros nombres:
|
|
Sin intervención: Control Group
Participants in this group maintained their usual sedentary routine and did not receive an additional exercise program during the study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Maximal Oxygen Uptake (VO2max)
Periodo de tiempo: Baseline and 6 weeks
|
VO2max was assessed using a maximal exercise test on a cycle ergometer with breath-by-breath respiratory gas analysis.
VO2max values were recorded in ml/kg/min before and after the 6-week intervention.
|
Baseline and 6 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Resting Heart Rate
Periodo de tiempo: Baseline and 6 weeks
|
Resting heart rate was measured in the morning after 10 minutes of seated rest using a heart rate monitor.
Values were recorded in beats per minute before and after the 6-week intervention.
|
Baseline and 6 weeks
|
|
Change in 6-Minute Walk Test Distance
Periodo de tiempo: Baseline and 6 weeks
|
Functional exercise capacity was assessed using the 6-minute walk test.
The total distance covered in 6 minutes was recorded in meters before and after the 6-week intervention.
|
Baseline and 6 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Sezer Taştan, phD, Ankara Demirspor
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ST-SIT-VO2MAX-2026
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .